Combining mechanistic quantitative systems pharmacology modeling and patient-derived organoid testing in MET-aberrant non-small cell lung cancer for high-throughput combination efficacy analysis and personalized treatment design
结合机制定量系统药理学建模和患者来源的类器官测试,对MET异常的非小细胞肺癌进行高通量联合疗效分析和个体化治疗设计
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1685468
Hu, Jingjing; Zhao, Yanyong; Rao, Qi; Li, Geli; Jiao, Zichen; Wang, Haoxiang; Qu, Yuchen; Xu, Shihui; Gu, Zhongze; Wang, Tao; Chen, Zaozao; Zhao, Chen; Zhou, Guohua